ITMI991299A0 - Uso di anticorpi contro antigeni di superficie per il trattamento dell a malattia trapianto contro ospite - Google Patents

Uso di anticorpi contro antigeni di superficie per il trattamento dell a malattia trapianto contro ospite

Info

Publication number
ITMI991299A0
ITMI991299A0 IT99MI001299A ITMI991299A ITMI991299A0 IT MI991299 A0 ITMI991299 A0 IT MI991299A0 IT 99MI001299 A IT99MI001299 A IT 99MI001299A IT MI991299 A ITMI991299 A IT MI991299A IT MI991299 A0 ITMI991299 A0 IT MI991299A0
Authority
IT
Italy
Prior art keywords
graft
versus
treatment
antibody against
host disease
Prior art date
Application number
IT99MI001299A
Other languages
English (en)
Inventor
Josee Golay
Martino Introna
Alessandro Rambaldi
Andrea Biondi
Original Assignee
Consiglio Nazionale Ricerche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Consiglio Nazionale Ricerche filed Critical Consiglio Nazionale Ricerche
Priority to IT1999MI001299A priority Critical patent/ITMI991299A1/it
Publication of ITMI991299A0 publication Critical patent/ITMI991299A0/it
Priority to JP2001502875A priority patent/JP2003501482A/ja
Priority to CZ20014450A priority patent/CZ20014450A3/cs
Priority to PCT/EP2000/005212 priority patent/WO2000076542A1/en
Priority to EP00940332A priority patent/EP1185299B1/en
Priority to IL14693400A priority patent/IL146934A0/xx
Priority to HU0201600A priority patent/HUP0201600A3/hu
Priority to PL00352860A priority patent/PL352860A1/xx
Priority to KR1020017015954A priority patent/KR20020026455A/ko
Priority to ES00940332T priority patent/ES2278616T3/es
Priority to TR2001/03581T priority patent/TR200103581T2/xx
Priority to EEP200100667A priority patent/EE200100667A/xx
Priority to CA002376288A priority patent/CA2376288A1/en
Priority to PT00940332T priority patent/PT1185299E/pt
Priority to DK00940332T priority patent/DK1185299T3/da
Priority to NZ515992A priority patent/NZ515992A/xx
Priority to SI200030932T priority patent/SI1185299T1/sl
Priority to HK02105388.7A priority patent/HK1043549B/zh
Priority to AU55303/00A priority patent/AU774206B2/en
Priority to CNB008088330A priority patent/CN1253208C/zh
Priority to SK1813-2001A priority patent/SK18132001A3/sk
Priority to DE60033030T priority patent/DE60033030T2/de
Publication of ITMI991299A1 publication Critical patent/ITMI991299A1/it
Priority to ZA200110004A priority patent/ZA200110004B/xx
Priority to BG106193A priority patent/BG106193A/bg
Priority to NO20016035A priority patent/NO20016035L/no
Priority to IS6195A priority patent/IS6195A/is
Priority to US11/498,103 priority patent/US20070014785A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2887—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against CD20
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
IT1999MI001299A 1999-06-11 1999-06-11 Uso di anticorpi contro antigeni di superficie per il trattamento della malattia trapianto contro ospite ITMI991299A1 (it)

Priority Applications (27)

Application Number Priority Date Filing Date Title
IT1999MI001299A ITMI991299A1 (it) 1999-06-11 1999-06-11 Uso di anticorpi contro antigeni di superficie per il trattamento della malattia trapianto contro ospite
DE60033030T DE60033030T2 (de) 1999-06-11 2000-06-07 Verwendung von gegen cd20 gerichteten antikörpern zur behandlung der graft-versus-host-krankheit
CA002376288A CA2376288A1 (en) 1999-06-11 2000-06-07 Use of antibodies against cd20 for the treatment of the graft versus host disease
DK00940332T DK1185299T3 (da) 1999-06-11 2000-06-07 Anvendelse af antistoffer mod CD20 til behandling af graft versus host disease
PCT/EP2000/005212 WO2000076542A1 (en) 1999-06-11 2000-06-07 Use of antibodies against cd20 for the treatment of the graft versus host disease
EP00940332A EP1185299B1 (en) 1999-06-11 2000-06-07 Use of antibodies against cd20 for the treatment of the graft versus host disease
IL14693400A IL146934A0 (en) 1999-06-11 2000-06-07 Use of antibodies afainst cd20 for the treatment of the graft versus host disease
HU0201600A HUP0201600A3 (en) 1999-06-11 2000-06-07 Use of antibodies against cd20 for the treatment of the graft versus host disease
PL00352860A PL352860A1 (en) 1999-06-11 2000-06-07 Use of antibodies against cd20 for the treatment of the graft versus host disease
KR1020017015954A KR20020026455A (ko) 1999-06-11 2000-06-07 이식편 대 숙주반응질환의 치료를 위한 씨디20에 대한 항체
ES00940332T ES2278616T3 (es) 1999-06-11 2000-06-07 Uso de anticuerpos contra cd20 para el tratamiento de la enfermedad de injerto contra huesped.
TR2001/03581T TR200103581T2 (tr) 1999-06-11 2000-06-07 Graft versus host hastalığı tedavisinde CD20' ye karşı antikorların kullanımı.
EEP200100667A EE200100667A (et) 1999-06-11 2000-06-07 CD20 vastaste antikehade kasutamine transplantaadi peremehevastase reaktsiooni raviks
JP2001502875A JP2003501482A (ja) 1999-06-11 2000-06-07 移植片対宿主疾患の処置のためのｃｄ２０に対する抗体の使用
PT00940332T PT1185299E (pt) 1999-06-11 2000-06-07 Utilização de anticorpos contra cd20 para o tratamento da doença enxerto versus hospedeiro
CZ20014450A CZ20014450A3 (cs) 1999-06-11 2000-06-07 Farmaceutický prostředek
NZ515992A NZ515992A (en) 1999-06-11 2000-06-07 Use of antibodies against CD20 for the treatment of the graft versus host disease
SI200030932T SI1185299T1 (sl) 1999-06-11 2000-06-07 Uporaba protiteles proti cd20 za zdravljenje reakcije presadka proti gostitelju
HK02105388.7A HK1043549B (zh) 1999-06-11 2000-06-07 利用抗cd20抗体治疗移植物抗宿主疾病
AU55303/00A AU774206B2 (en) 1999-06-11 2000-06-07 Use of antibodies against CD20 for the treatment of the graft versus host disease
CNB008088330A CN1253208C (zh) 1999-06-11 2000-06-07 利用抗cd20抗体治疗移植物抗宿主疾病
SK1813-2001A SK18132001A3 (sk) 1999-06-11 2000-06-07 Použitie protilátky proti antigénom
ZA200110004A ZA200110004B (en) 1999-06-11 2001-12-05 Use of antibodies against CD20 for the treatment of the graft versus host disease.
BG106193A BG106193A (bg) 1999-06-11 2001-12-07 Използване на антитела срещу cd20 за лечение на заболявания при трансплантации
NO20016035A NO20016035L (no) 1999-06-11 2001-12-10 Anvendelse av antistoff mot CD20 ved behandling av avstötning av implantanter
IS6195A IS6195A (is) 1999-06-11 2001-12-10 Notkun á mótefnum gegn CD20 til meðhöndlunar á þegahöfnunarveiki
US11/498,103 US20070014785A1 (en) 1999-06-11 2006-08-03 Use of antibodies against CD20 for the treatment of the graft versus host disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT1999MI001299A ITMI991299A1 (it) 1999-06-11 1999-06-11 Uso di anticorpi contro antigeni di superficie per il trattamento della malattia trapianto contro ospite

Publications (2)

Publication Number Publication Date
ITMI991299A0 true ITMI991299A0 (it) 1999-06-11
ITMI991299A1 ITMI991299A1 (it) 2000-12-11

Family

ID=11383150

Family Applications (1)

Application Number Title Priority Date Filing Date
IT1999MI001299A ITMI991299A1 (it) 1999-06-11 1999-06-11 Uso di anticorpi contro antigeni di superficie per il trattamento della malattia trapianto contro ospite

Country Status (26)

Country Link
US (1) US20070014785A1 (it)
EP (1) EP1185299B1 (it)
JP (1) JP2003501482A (it)
KR (1) KR20020026455A (it)
CN (1) CN1253208C (it)
AU (1) AU774206B2 (it)
BG (1) BG106193A (it)
CA (1) CA2376288A1 (it)
CZ (1) CZ20014450A3 (it)
DE (1) DE60033030T2 (it)
DK (1) DK1185299T3 (it)
EE (1) EE200100667A (it)
ES (1) ES2278616T3 (it)
HK (1) HK1043549B (it)
HU (1) HUP0201600A3 (it)
IL (1) IL146934A0 (it)
IS (1) IS6195A (it)
IT (1) ITMI991299A1 (it)
NO (1) NO20016035L (it)
NZ (1) NZ515992A (it)
PL (1) PL352860A1 (it)
PT (1) PT1185299E (it)
SK (1) SK18132001A3 (it)
TR (1) TR200103581T2 (it)
WO (1) WO2000076542A1 (it)
ZA (1) ZA200110004B (it)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000067796A1 (en) 1999-05-07 2000-11-16 Genentech, Inc. Treatment of autoimmune diseases with antagonists which bind to b cell surface markers
US20030133939A1 (en) 2001-01-17 2003-07-17 Genecraft, Inc. Binding domain-immunoglobulin fusion proteins
US7754208B2 (en) 2001-01-17 2010-07-13 Trubion Pharmaceuticals, Inc. Binding domain-immunoglobulin fusion proteins
TWI335821B (en) * 2002-12-16 2011-01-11 Genentech Inc Immunoglobulin variants and uses thereof
CN1316019C (zh) * 2002-12-26 2007-05-16 中国医学科学院中国协和医科大学血液学研究所血液病医院 抗cd20嵌合抗体突变体基因及其应用
EP1613350B1 (en) 2003-04-09 2009-03-18 Genentech, Inc. Therapy of autoimmune disease in a patient with an inadequate response to a tnf-alpha inhibitor
CN1802388B (zh) 2003-05-09 2011-01-05 杜克大学 Cd20特异抗体及使用它们的方法
JP2007526220A (ja) 2003-06-05 2007-09-13 ジェネンテック・インコーポレーテッド Ｂ細胞疾患の併用療法
CA2560751A1 (en) * 2004-03-22 2005-10-06 The Ohio State University Research Foundation Methods for transfecting natural killer cells
AU2005249566B2 (en) 2004-06-04 2010-11-11 Genentech, Inc. Method for treating multiple sclerosis
AU2005274905B2 (en) 2004-08-04 2010-12-23 Mentrik Biotech, Llc Variant Fc regions
ZA200709956B (en) 2005-05-20 2009-02-25 Genentech Inc Pretreatment of a biological sample from an autoimmune disease subject
RU2423381C2 (ru) 2005-07-25 2011-07-10 Трабьон Фармасьютикалз, Инк. Снижение количества в-клеток с использованием cd37-специфических и cd20-специфических связывающих молекул
RU2421242C2 (ru) 2005-07-25 2011-06-20 Трабьон Фармасьютикалз, Инк. Применение однократной дозы cd20-специфических связывающих молекул
MY149159A (en) 2005-11-15 2013-07-31 Hoffmann La Roche Method for treating joint damage
ES2618543T3 (es) 2005-11-23 2017-06-21 Genentech, Inc. Métodos y composiciones relacionados con ensayos de linfocitos B
CN101008291B (zh) * 2006-01-26 2010-05-12 金海产品有限公司 用于水池清洁机的密封盒装置
NZ573646A (en) 2006-06-12 2012-04-27 Wyeth Llc Single-chain multivalent binding proteins with effector function
CA2584494A1 (en) * 2007-03-27 2008-09-27 Jeffrey A. Medin Vector encoding therapeutic polypeptide and safety elements to clear transduced cells
WO2009001545A1 (ja) 2007-06-22 2008-12-31 Sapporo Medical University 移植片対宿主疾患の検査および治療方法
KR102055873B1 (ko) 2007-07-09 2019-12-13 제넨테크, 인크. 폴리펩티드의 재조합 생산 동안의 디술피드 결합 환원의 방지
MX2010000970A (es) 2007-07-31 2010-03-09 Regeneron Pharma Anticuerpos humanos contra cd20 humano y metodo para utilizarlos.
HUE030134T2 (en) 2007-10-16 2017-04-28 Zymogenetics Inc Combination of transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI) and anti-CD20 agents for the treatment of autoimmune diseases
EP2077281A1 (en) 2008-01-02 2009-07-08 Bergen Teknologioverforing AS Anti-CD20 antibodies or fragments thereof for the treatment of chronic fatigue syndrome
US8568709B2 (en) 2008-03-20 2013-10-29 University Health Network Thymidylate kinase fusions and uses thereof
RU2531754C2 (ru) 2008-04-11 2014-10-27 ЭМЕРДЖЕНТ ПРОДАКТ ДИВЕЛОПМЕНТ СИЭТЛ,ЭлЭлСи,US Связывающееся с cd37 иммунотерапевтическое средство и его комбинация с бифункциональным химиотерапевтическим средством
AR073295A1 (es) 2008-09-16 2010-10-28 Genentech Inc Metodos para tratar la esclerosis multiple progresiva. articulo de fabricacion.
WO2010075249A2 (en) 2008-12-22 2010-07-01 Genentech, Inc. A method for treating rheumatoid arthritis with b-cell antagonists
HRP20200768T4 (hr) 2009-08-11 2025-03-28 F. Hoffmann - La Roche Ag Proizvodnja proteina u mediju za uzgoj stanica bez glutamina
KR20130009760A (ko) 2010-02-10 2013-01-23 이뮤노젠 아이엔씨 Ｃｄ２０ 항체 및 이의 용도
JOP20200236A1 (ar) 2012-09-21 2017-06-16 Regeneron Pharma الأجسام المضادة لمضاد cd3 وجزيئات ربط الأنتيجين ثنائية التحديد التي تربط cd3 وcd20 واستخداماتها
TWI701042B (zh) 2014-03-19 2020-08-11 美商再生元醫藥公司 用於腫瘤治療之方法及抗體組成物
KR102614189B1 (ko) 2014-11-17 2023-12-18 리제너론 파아마슈티컬스, 인크. Cd3xcd20 이특이적 항체를 이용한 종양의 치료 방법
EP3303373B1 (en) 2015-05-30 2020-04-08 Molecular Templates, Inc. De-immunized, shiga toxin a subunit scaffolds and cell-targeting molecules comprising the same
HUE057952T2 (hu) 2015-06-24 2022-06-28 Hoffmann La Roche Anti-transzferrin receptor antitestek testreszabott affinitással
WO2017053469A2 (en) 2015-09-21 2017-03-30 Aptevo Research And Development Llc Cd3 binding polypeptides
TWI873952B (zh) 2015-10-02 2025-02-21 瑞士商赫孚孟拉羅股份公司 雙特異性抗‐人類cd20/人類轉鐵蛋白受體抗體及使用方法
AR106189A1 (es) 2015-10-02 2017-12-20 Hoffmann La Roche ANTICUERPOS BIESPECÍFICOS CONTRA EL A-b HUMANO Y EL RECEPTOR DE TRANSFERRINA HUMANO Y MÉTODOS DE USO
WO2018106945A1 (en) 2016-12-07 2018-06-14 Progenity Inc. Gastrointestinal tract detection methods, devices and systems
WO2018183929A1 (en) 2017-03-30 2018-10-04 Progenity Inc. Treatment of a disease of the gastrointestinal tract with an immune modulatory agent released using an ingestible device
WO2019246317A1 (en) 2018-06-20 2019-12-26 Progenity, Inc. Treatment of a disease or condition in a tissue originating from the endoderm
WO2019246312A1 (en) 2018-06-20 2019-12-26 Progenity, Inc. Treatment of a disease of the gastrointestinal tract with an immunomodulator
CA3110513A1 (en) 2018-08-31 2020-03-05 Regeneron Pharmaceuticals, Inc. Dosing strategy that mitigates cytokine release syndrome for cd3/c20 bispecific antibodies
EP3883635A1 (en) 2018-11-19 2021-09-29 Progenity, Inc. Methods and devices for treating a disease with biotherapeutics
CN115666704B (zh) 2019-12-13 2025-09-26 比特比德科有限责任公司 用于将治疗剂递送至胃肠道的可摄取装置

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5272082A (en) * 1992-03-30 1993-12-21 The Wistar Institute Of Anatomy & Biology Cytotoxic T-ALL cell lines and uses therefor
US5736137A (en) * 1992-11-13 1998-04-07 Idec Pharmaceuticals Corporation Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
JP2000511539A (ja) * 1996-05-31 2000-09-05 ジェネティック・セラピー・インコーポレイテッド 負の選択マーカーをコード化するポリヌクレオチドを含むｔ細胞による対宿主性移植片病の予防
GB9705744D0 (en) * 1997-03-20 1997-05-07 Davies Alison M Methods for selecting cells and their uses

Also Published As

Publication number Publication date
NO20016035D0 (no) 2001-12-10
HUP0201600A3 (en) 2005-04-28
WO2000076542A1 (en) 2000-12-21
IS6195A (is) 2001-12-10
PL352860A1 (en) 2003-09-08
DK1185299T3 (da) 2007-05-21
EE200100667A (et) 2003-02-17
PT1185299E (pt) 2007-03-30
CN1355712A (zh) 2002-06-26
JP2003501482A (ja) 2003-01-14
ES2278616T3 (es) 2007-08-16
TR200103581T2 (tr) 2002-08-21
CA2376288A1 (en) 2000-12-21
NZ515992A (en) 2004-01-30
CZ20014450A3 (cs) 2002-04-17
HK1043549A1 (en) 2002-09-20
EP1185299B1 (en) 2007-01-17
HUP0201600A2 (en) 2002-08-28
HK1043549B (zh) 2006-09-01
DE60033030T2 (de) 2007-05-31
KR20020026455A (ko) 2002-04-10
EP1185299A1 (en) 2002-03-13
IL146934A0 (en) 2002-08-14
CN1253208C (zh) 2006-04-26
NO20016035L (no) 2002-02-11
SK18132001A3 (sk) 2002-05-09
DE60033030D1 (de) 2007-03-08
AU774206B2 (en) 2004-06-17
US20070014785A1 (en) 2007-01-18
BG106193A (bg) 2002-08-30
ZA200110004B (en) 2003-02-26
AU5530300A (en) 2001-01-02
ITMI991299A1 (it) 2000-12-11

Similar Documents

Publication Publication Date Title
ITMI991299A0 (it) Uso di anticorpi contro antigeni di superficie per il trattamento dell a malattia trapianto contro ospite
EP1391464A4 (en) MONOCLONAL ANTI-CD-40 ANTIBODY
NL300269I2 (nl) Werkwijze voor het vervaardigen van een humaan-papillomavirusvaccin
NO20015227L (no) Fremgangsmate for a oke effektiviteten til anti-cancer midler
EE200100383A (et) L-fenüülefriinvesinikkloriidi valmistamise meetod
IT1319251B1 (it) Metodo per la preparazione di 5-carbossiftalide.
IS6381A (is) Nýjung við notkun mótefna í bóluefni
EP1700122A4 (en) IMMUNOASSAYS, HAPTENE, IMMUNOGENES AND ANTIBODIES FOR ANTI-HIV THERAPEUTICS
MA27184A1 (fr) Dosage d'anticorps anti-ingap
ITRM20030196A1 (it) Uso di reagenti per la preparazione di un medicamento
IT1320306B1 (it) Struttura per il sopporto di un albero a gomiti.
AU6523200A (en) Vitronectin receptor antagonists useful for the treatment of strokes
IT248147Y1 (it) Cassero perfezionato per la costruzione di pavimenti, solai o simili
ITRE990116A0 (it) Metodo per fabbricare piastrelle aventi l'aspetto della pietra di cava spaccata.
ITRM20040288A1 (it) Uso della 7-t-butossiimminometilcamptotecina per la preparazione di un medicamento per il trattamento delle neoplasie dell'utero.
ITMI20011237A0 (it) Uso della yohimbina per la preparazione di farmaci ad attivita' immunobiologica
IT250791Y1 (it) Dispositivo per la misurazione dell'inclinazione di superfici.
ES1050194Y (es) Alisador de superficies.
IT1307295B1 (it) Procedimento per la preparazione di filati ondee o compensina.
IT1307938B1 (it) Dispositivo per il sostegno di elementi edilizi prefabbricati,particolarmente per manufatti prefabbricati in calcestruzzo o simili,
ITGE20000007A0 (it) Dispositivo ad azionamento centralizzato, per il movimento alternato di traslazione orizzontale e di sollevamento-abbassamento dell'elevare
ES1046145Y (es) Estructura para soporte de paneles expositores de piezas ceramicas de recubrimiento.
IT1318330B1 (it) Procedimento per la formazione di elementi ceramici angolari confinitura superficiale uniforme.
IT1310022B1 (it) Rullo per via a rulli per il trasferimento di bramme calde o simili.
ITRM20010292A1 (it) Uso dell'acetil l-carnitina per la preparazione di un medicamento peril trattamento dell'anedonia.